Literature DB >> 31917839

A role for NFAT signaling in ABC-DLBCL.

Jagan R Muppidi1.   

Abstract

Mesh:

Substances:

Year:  2020        PMID: 31917839      PMCID: PMC6952828          DOI: 10.1182/blood.2019004199

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.

Authors:  Ryan M Young; James D Phelan; Wyndham H Wilson; Louis M Staudt
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

2.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

3.  Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.

Authors:  Wyndham H Wilson; Ryan M Young; Roland Schmitz; Yandan Yang; Stefania Pittaluga; George Wright; Chih-Jian Lih; P Mickey Williams; Arthur L Shaffer; John Gerecitano; Sven de Vos; Andre Goy; Vaishalee P Kenkre; Paul M Barr; Kristie A Blum; Andrei Shustov; Ranjana Advani; Nathan H Fowler; Julie M Vose; Rebecca L Elstrom; Thomas M Habermann; Jacqueline C Barrientos; Jesse McGreivy; Maria Fardis; Betty Y Chang; Fong Clow; Brian Munneke; Davina Moussa; Darrin M Beaupre; Louis M Staudt
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

4.  Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.

Authors:  Lloyd T Lam; George Wright; R Eric Davis; Georg Lenz; Pedro Farinha; Lenny Dang; John W Chan; Andreas Rosenwald; Randy D Gascoyne; Louis M Staudt
Journal:  Blood       Date:  2007-12-26       Impact factor: 22.113

5.  CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.

Authors:  Mélanie Juilland; Montserrat Gonzalez; Tabea Erdmann; Yara Banz; Zala Jevnikar; Stephan Hailfinger; Alexandar Tzankov; Michael Grau; Georg Lenz; Urban Novak; Margot Thome
Journal:  Blood       Date:  2016-01-08       Impact factor: 22.113

6.  Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma.

Authors:  Philip Bucher; Tabea Erdmann; Paula Grondona; Wendan Xu; Anja Schmitt; Christoph Schürch; Myroslav Zapukhlyak; Caroline Schönfeld; Edgar Serfling; Daniela Kramer; Michael Grau; Pavel Klener; Claudia Lengerke; Klaus Schulze-Osthoff; Georg Lenz; Stephan Hailfinger
Journal:  Blood       Date:  2020-01-09       Impact factor: 22.113

7.  B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.

Authors:  Li Li; Jun Zhang; Juan Chen; Zijun Y Xu-Monette; Yi Miao; Min Xiao; Ken H Young; Sa Wang; L Jeffrey Medeiros; Michael Wang; Richard J Ford; Lan V Pham
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

  7 in total
  2 in total

Review 1.  Role of NFAT in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies.

Authors:  Ilenia Sana; Maria Elena Mantione; Piera Angelillo; Marta Muzio
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

2.  Identification of pimavanserin tartrate as a potent Ca2+-calcineurin-NFAT pathway inhibitor for glioblastoma therapy.

Authors:  Zhen-Zhen Liu; Xiao-Ning Liu; Rui-Cheng Fan; Yu-Ping Jia; Qing-Ke Zhang; Xin-Qing Gao; Yu-Qing Wang; Meng-Qing Yang; Li-Zhen Ji; Yong-Qing Zhou; Hong-Li Li; Ping Li; Bo Tang
Journal:  Acta Pharmacol Sin       Date:  2021-08-06       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.